secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2022-03-30T23:59:59+00:00
Accession:  0001193125-22-089787
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma signs 4-year license for Boston office/lab space; monthly rent $200,700
--------------------------------------------------------------------------------

- Lease covers ~13,000 sq ft at 40 Guest Street, Boston; term April 15, 2022 to April 14, 2026.
- Monthly base rent $200,700 first year, escalating 4% annually: Year2 $208,728, Year3 $217,077, Year4 $225,760.
- Initial payment due at signing: $652,220.40 plus parking fees (20 spaces).
- Company plans to relocate corporate headquarters to the Premises in April 2022.
- Licensor (MIL 40G) provides services including gases, chemicals, equipment, IT, security.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522089787/0001193125-22-089787-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522089787/d339157d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-089787

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer